scispace - formally typeset
D

David Cameron

Researcher at University of Oslo

Publications -  1765
Citations -  141776

David Cameron is an academic researcher from University of Oslo. The author has contributed to research in topics: Large Hadron Collider & Breast cancer. The author has an hindex of 154, co-authored 1586 publications receiving 126067 citations. Previous affiliations of David Cameron include Universidade Nova de Lisboa & Cameron International.

Papers
More filters
Journal ArticleDOI

Search for doubly and singly charged Higgs bosons decaying into vector bosons in multi-lepton final states with the ATLAS detector using proton-proton collisions at √s = 13 TeV

Georges Aad, +2870 more
- 28 Jan 2021 - 
TL;DR: In this paper, a search for charged Higgs bosons decaying into W±W± or W±Z bosons is performed, involving experimental signatures with two leptons of the same charge, or three or four lepton with a variety of charge combinations, missing transverse momentum and jets.
Journal ArticleDOI

Adhesion of Ti and TiC Coatings on PMMA Subject to Plasma Treatment: Effect of Intermediate Layers of Al2O3 and TiO2 Deposited by Atomic Layer Deposition

Tommi Kääriäinen, +2 more
- 14 Oct 2009 - 
TL;DR: In this article, a nanometer-scale thickness adhesion layer of TiO 2 or Al 2 O 3 was deposited by low temperature atomic layer deposition (ALD) prior to magnetron sputtering.
Journal ArticleDOI

Management of chemotherapy-associated febrile neutropenia

David Cameron
- 01 Sep 2009 - 
TL;DR: It is, therefore, paramount to have a well thought out and rigorously implemented care protocol for febrile neutropenia, involving patients, family/carers and health-care professionals in both primary and secondary care, to ensure early detection and effective management.
Journal ArticleDOI

Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer in the randomised UK TACT2 trial (CRUK/05/19): a multicentre, phase 3, open-label, randomised, controlled trial

David Cameron, +23 more
- 01 Jul 2017 - 
TL;DR: No significant difference was seen in the proportions of patients free from TTR events between the accelerated and standard epirubicin groups, and significantly more patients taking CMF than those taking capecitabine had clinically relevant worsening of quality of life at end of treatment.
Journal ArticleDOI

Measurement of the forward-backward asymmetry of electron and muon pair-production in pp collisions at √s=7 TeV with the ATLAS detector

Georges Aad, +2872 more
- 09 Sep 2015 - 
TL;DR: In this article, measurements from the ATLAS experiment of the forward-backward asymmetry in the reaction pp -> Z/gamma* -> l(+)l(-, with l being electrons or muons, and the extraction of the effective weak mixing angle.